Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.

Candidiasis in HIV/AIDS patients continues to be a public health problem. Effective antifungal therapies are few in number and have inherent problems such as selecting for drug-resistant strains of Candida species. To evaluate the state of Candida colonization of the oral and vaginal mucosa, we recruited 80 women, both HIV-infected and HIV-uninfected, from the Women's Interagency HIV Study (WIHS). Diet diaries were collected by participants to examine the role of diet on fungal growth. Baseline studies were initially done in participants that followed the colonization of both mucosal sites over 0-90 days. The most common Candida species from both groups of patients were C. albicans and C. glabrata. Among the HIV-infected cohort, the percentage of participants who were positive for Candida spp. was higher than in the HIV-uninfected control group. Furthermore, the frequency of colonization (1 episode versus >1 episode) was also increased in the HIV-infected cohort. These data indicate that Candida species remain an important component of the microbial community in both populations.

[1]  N. Gow,et al.  Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host. , 2000, Microbiology.

[2]  T. Winn,et al.  Oral Candida in HIV-infected heterosexuals and intravenous drug users in Thailand. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[3]  J. Sobel,et al.  Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. , 2004, The New England journal of medicine.

[4]  Patrick M. Gillevet,et al.  Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals , 2010, PLoS pathogens.

[5]  N. Chauhan,et al.  The Ssk1p Response Regulator and Chk1p Histidine Kinase Mutants of Candida albicans Are Hypersensitive to Fluconazole and Voriconazole , 2007, Antimicrobial Agents and Chemotherapy.

[6]  L. Kalish,et al.  The Women's Interagency HIV Study. WIHS Collaborative Study Group. , 1998, Epidemiology.

[7]  S. Vermund,et al.  Prevalence, Incidence, and Recurrence of Oral Lesions Among HIV-Infected Patients on HAART in Alabama: A Two-Year Longitudinal Study , 2011, Southern medical journal.

[8]  S. G. Chadwick,et al.  Survey of Vaginal-Flora Candida Species Isolates from Women of Different Age Groups by Use of Species-Specific PCR Detection , 2008, Journal of Clinical Microbiology.

[9]  N. Gow,et al.  Growth kinetics and morphology of colonies of the filamentous form of Candida albicans. , 1982, Journal of general microbiology.

[10]  P. Fidel,et al.  Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. , 2004, AIDS patient care and STDs.

[11]  P. Fidel Distinct protective host defenses against oral and vaginal candidiasis. , 2002, Medical mycology.

[12]  J. Chmiel,et al.  AIDS-defining opportunistic illnesses in US patients, 1994–2007: a cohort study , 2010, AIDS.

[13]  J. Sobel Treatment of vaginal Candida infections , 2002, Expert opinion on pharmacotherapy.

[14]  J. Meurman Probiotics: do they have a role in oral medicine and dentistry? , 2005, European journal of oral sciences.

[15]  J. Saunus,et al.  Cellular and molecular mechanisms of resistance to oral Candida albicans infections. , 2008, Frontiers in bioscience : a journal and virtual library.

[16]  M. Young,et al.  The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench , 2005, Clinical Diagnostic Laboratory Immunology.

[17]  G. Reid,et al.  Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR‐1 and Lactobacillus reuteri RC‐14 , 2009, Letters in applied microbiology.

[18]  Joseph Feldman,et al.  The Women's Interagency HIV Study , 1998 .

[19]  D. Soll,et al.  DNA fingerprinting Candida species. , 2009, Methods in molecular biology.